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Abstract
Background: Depression and falls are common and co-exist for older people. Safe management of each of these conditions
is important to quality of life.
Methods: A cross-sectional survey was used to examine medication use associated with injurious and non-injurious falls in
21,900 community-dwelling adults, aged 60 years or over from 383 Australian general practices recruited for the DEPS-GP
Project. Falls and injury from falls, medication use, depressive symptoms (Primary Health Questionnaire (PHQ-9)), clinical
morbidity, suicidal ideation and intent, health status (SF-12 Health Survey), demographic and lifestyle information was
reported in a standardised survey.
Findings: Respondents were 71.8 years (sd 7.7) of age and 58.4% were women. 24% 11% and 8% reported falls, fall related
injury, and sought medical attention respectively. Antidepressant use (odds ratio, OR: 1.46; 95% confidence interval, 95%CI:
1.25, 1.70), questionable depression (5–14 on PHQ OR: 1.32, 95%CI: 1.13, 1.53) and clinically significant symptoms of
depression (15 or more on PHQ OR: 1.70, 95%CI: 1.14, 1.50) were independently associated with multiple falls. SSRI use was
associated with the highest risk of multiple falls (OR: 1.66, 95%CI: 1.36, 2.02) amongst all psychotropic medications. Similar
associations were observed for injurious falls. Over 60% of those with four accumulated risk factors had multiple falls in the
previous year (OR: 3.40, 95%CI: 1.79, 6.45); adjusted for other demographic and health factors.
Interpretation: Antidepressant use (particularly SSRIs) was strongly associated with falls regardless of presence of depressive
symptoms. Strategies to prevent falls should become a routine part of the management of older people with depression.
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Falls are an important public heath issue for older people,
health providers and policy makers. They are associated with
increased risk of placement in residential care [6], hospitalisation
[6] and mortality.[7] Up to 35% of all older people fall every year,
with 68% of fallers sustaining an injury and 24% requiring health
services[1]. Fractures occur because of falls in 4% of cases[8], with
hip fractures being associated with the highest morbidity and
mortality[6]. For those with depression, the morbidity associated
with falls compounds disability. The majority of older people fall
once factors distinguishing single fallers from multiple fallers are
not well understood.
As part of a randomised trial to improve detection and
management of depression in older Australians, the DEPS-GP
Project, 20,000 primary care patients, aged 60 years or older,
reported information about depressive symptoms, medications,

Introduction
Older people who fall are twice as likely to be depressed
compared with those who do not fall[1]. Depression is common in
old age[2], is treatable, and outcomes improve with effective
antidepressant therapy, and this could lead to a decrease in the
morbidity associated with falls. However, antidepressant use can
also increase the risk of falls, both for those in the community[3]
and in residential care.[4,5] The use of psychotropic medications
increases the risk of falls[3], but it is unclear whether this risk is the
same across a group of medications (for example, antidepressants),
specific to a certain class of drugs (eg selective serotonin reuptake
inhibitors, SSRIs), or whether the effect of the drug is independent
of concurrent mental health morbidity (for example, presence and
severity of depressive symptoms).
PLoS ONE | www.plosone.org
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exercise (such as walking or sport) on five or more days of the
week?’’ This question has been shown to efficiently discriminate
between physically active and sedentary older adults.[12]
Social support was measured with the Duke Social Support section
of the Duke Multidisciplinary Assessment Tool, asking respondents to decide between 5 levels of response ‘‘none of the time’’ to
‘‘all of the time’’ across questions about relationships with family
and friends [13]. A score between 8 (lesser) and 40 (greater social
support) was obtained from the eight item option. The score was
divided into quartiles for analysis.
The body mass index (BMI) was calculated by dividing selfreported weight (in kilograms) by height (in metres) squared. BMI
was categorised: underweight (BMI,18), normal weight
(18#BMI,25), overweight (25#BMI,30) and obese (BMI$30).
Common morbidities of old age were ascertained by asking
participants if they had ever been told by a doctor that they had
arthritis, diabetes, hypertension, stroke, heart attack or angina,
heart failure, poor circulation to the legs, asthma, emphysema,
osteoporosis and cancer. Arthritis and stroke were left as individual
explanatory variables; the remainder were summed and recoded
into four categories, 0, 1, 2, and 3 or more co-morbidities.
The two questions assessing ever and current smoking (‘‘Have you
ever smoked cigarettes, pipe, cigars?’’ and ‘‘Are you currently
smoking?’’) were transformed to never smoked, ex-smoker, current
smoker. Alcohol use was coded as risk drinking if women reported
consuming more than 7 standard drinks in a week and men
consumed more than 14 drinks in a week.[14]
Health status was assessed using the SF-12[15] summary scores
for Mental Health (SF-12 MCS score) and Physical Health (SF-12
PCS score) (range of scores 0 to 100) dichotomised to less than or
equal to 40 and greater than 40 based on the mean score of the
Australian population (mean 50, standard deviation 10).[16]
Confidence about not falling was ascertained with the question:
‘‘How confident are you that you can do all your daily activities
without falling?’’ with three level responses; not at all, quite and
completely confident. Anxiety was ascertained using the anxiety
subscale of the Hospital Anxiety and Depression Scale (HADS)[17];
a total score lower than 8, 8 to 10, and greater or equal 11 indicating
no, questionable or significant anxiety, respectively.
The primary outcome of interest in this study was falls, which
we assessed with the following questions: ‘‘In the past 12 months
have you: slipped, tripped or stumbled? (not including falls to the
ground);’’ ‘‘Have you had a fall to the ground? (not including
stumbles or trips).’’ Subjects who answered ‘yes’ to the latter were
then asked: ‘‘How many falls have you had during the past
12 months?’’; ‘‘Were you injured as a result of any of these falls?’’;
‘‘Did you need to seek medical attention (eg doctor, hospital)?’’
The last two questions recorded injury and severity of injury.

falls and health status. The aim of this cross-sectional study was to
investigate the risk factors associated with single, multiple and
injurious falls, especially related to depression and psychotropic
medication use.

Methods
Objectives
A cross-sectional survey of community dwelling older primary
care patients was used to investigate associations between
depressive symptoms, medication use, falls and fall-related injury.

Participants
Eligible participants were all patients aged 60 years or over
attending family physicians enrolled in the DEPS-GP project, a
clustered randomised trial designed to test the efficacy of a family
medicine based intervention to reduce depression and self-harm
behaviour in later life. Recruitment details are reported elsewhere in
detail[9]. Australian general practitioners listed on the Australasian
Medical Publishing Company Proprietary Limited database were
mailed an invitation to participate; Of the 772 who provided written
informed consented for participation, 383 (49.6% of those who
consented) contributed to the recruitment of patients. Participating
general practitioners held practice registers of all patients enrolled
with their practice and they mailed a questionnaire to those aged
60 years and over (n = 77,820 potential target population, on
average 203 patients per practitioner), with a request that the
questionnaire be returned in a reply-paid envelope even if those
contacted chose not to complete it. Of these, 22,251 questionnaires
(29%) were returned with written informed consent, 9,087 were
returned not completed, 2,934 were returned to the sender because
the person named on the envelope was not known at the address,
and 820 were not posted by the general practitioner (total response
rate = 64.9%). A small proportion of older adults who consented
were found to be ineligible because they were under 60 years of age
(n = 130). A further 221 had incomplete data on basic demographic
characteristics (age and gender) and were excluded from the analysis,
leaving a sample of 21,900 older people, of whom 21,596 reported
information on falls.

The measures
All variables were ascertained by self-report on a questionnaire
posted to participants and returned in a reply-paid envelope. Age,
gender, marital status, highest educational level achieved and
current living arrangements were ascertained using standard
questions.
Medication use. Participants listed their prescribed
medications on the questionnaire and they were coded into WHO
standard classification of medications groups by a trained research
assistant.[10] Antidepressants, hypnotics, anxiolytics, antipsychotics,
and other CNS acting drugs that included lithium, antiepileptic and
anti-parkinsonian medications were coded for this study.
The Patient Health Questionnaire (PHQ-9)[11] was used to
assess depressive symptoms: score lower than 5, between 5 and 14, and
greater than 14 indicate no, questionable and significant
depressive symptoms respectively. Suicidality was measured with
the question ‘Have you ever thought about or attempted to kill yourself in
your lifetime?’ The seven possible answers ranged from ‘no’ to ‘I
attempted to kill myself and really hoped to die’. Subjects who
acknowledged any suicidal thoughts or behaviour during their
lifetime were considered ‘‘ever suicidal’’. A similar question
assessed suicidal ideation over the preceding 12 months.
Physical activity was rated as Yes or No answer to the question:
‘‘As a rule, do you do at least half an hour of moderate or vigorous
PLoS ONE | www.plosone.org

Ethics
Participants gave written informed consent. The Human
Research Ethics Committee of the University of Western Australia
(number: RA/4/1/1107) and the Royal Australian College of
General Practitioners (number: 20040128) approved this study.

Statistical methods
The statistical package Stata 9.2 was used to analyse the data.
Participants were categorised into ‘‘fallers’’ (one or more falls to the
ground) and ‘‘non fallers’’. Fallers who sustained any injury were
further subcategorized and compared with all others, as even injury
not requiring medical attention may cause decreased function from
pain. Descriptive statistics were calculated for the groups of fallers
and non-fallers, and those who had sustained an injury from fall. The
association between falls and other measures was examined using
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univariate methods. To establish those risk factors independently
related to single, multiple and injurious falls, a logistic regression
model, controlling for all other variables in the model and adjusting
the standard errors for the effect of clustering (treating family
physician) was used. Accumulated risk was investigated by creating
variables describing the group with combinations of risk factors, eg
older age, female gender, and by testing the new composite risk
variable within the multivariable model.

using an SSRI fall and sustain injury. Both depression and the
treatment for depression were independently associated to
increased risk of falls with SSRI use being associated with the
highest risk of falls and injurious falls of all psychotropic agents.
Overall one quarter of community-dwelling adults aged 60 years
or older reported falling during the preceding 12 months.
We report the risk factors associated with single and multiple
falls in a community sample. Distinguishing features between those
that report falling once in a year and those that fall more than once
have not, to our knowledge, been previously reported. Female
gender, usually associated with falls, in this analysis is not associated
with sustaining multiple falls, but is independently associated with
injury. Depression is independently associated with multiple falls and
antidepressants are associated with all falls (1 fall, 2+ falls), and with
injury. Of the health issues examined, arthritis and poor health status
(as reflected by a low PCS score on the SF-36) were independently
associated with all falls and injury whereas stroke was associated with
multiple falls and fall with injury. It is possible that differing
mechanisms lead to a single ‘careless’ fall compared with multiple
falls. Risk factors identified here suggest that there is not necessarily a
dose response relationship between depression and falls. Those with
questionable and significant depression were more likely to report
multiple falls and fall related injury. Antidepressant use however was
related to all falls and fall related injury. The true cause of falls may
be better revealed by removing the noise of ‘‘accidental’’ falls i.e.
people who fall once but have no major risk factors related to the
main mechanisms causing falls and thus dilute the relationship. The
same proportion who fell once and who fell multiple times reported
an injury however, emphasising the need to address all falls in falls
prevention programs.

Results
This sample comprised community dwelling older people, with
only 54 people living in residential care facilities. The average age
was 71.8 years (sd 7.7) and 58.4% were women. The majority
(62.7%) were physically active and 24.0% lived alone (Table 1).
Despite 77.5% of participants reporting good, very good or
excellent health, 57.0% reported arthritis, 7.3% stroke, and only
20% had no other co-morbidities. The PHQ score showed that
77.7% of participants exhibited no significant symptoms of
depression, however 18.2% had at some time in their lives
considered suicide, and 10% had thought about or attempted
suicide in the last 12 months. The distribution of falls is shown in
Table 2 and characteristics of the participants in Table 1.
Falls were reported by 24.1% of participants and 35.2% had
tripped or stumbled. Less than half (47.3%) of those who had
fallen, fell only once, 27.1% fell twice and the remainder fell 3 or
more times. Almost half of fallers (45.4%) reported some form of
injury from a fall and 36.4% of fallers (8.8% of the whole sample)
sought medical attention for an injury (Table 2). Almost half,
1,080 (46%) of those who fell only once reported an injury and
1,208 (46%) of multiple fallers reported an injury. Twelve percent
of the sample were taking antidepressant medication, 2% were
taking antipsychotics and 5% hypnotics. Of the antidepressants,
SSRIs were the most commonly prescribed (6%), closely followed
by cyclic antidepressants (3.6%).
There were several differences between fallers and non-fallers
(Table 1), as well as between those who had or had not sustained
an injurious fall (Table 3).
Logistic regression, adjusting for the effect of clustering (family
physician), established the independence of the association of
depression, activity, antidepressant use with single and multiple
falls and fall related injury (Table 4). Analyses were further
adjusted for other demographic, health behaviours and health
related characteristics. Presence of depressive symptoms and
antidepressant use were independently associated with multiple
falls and injury but not having sustained a single fall. Those taking
as SSRIs were more likely to report a single fall (OR: 1.55 95% CI
1.26, 1.90), sustaining multiple falls (OR 1.66 95% CI 1.36, 2.02)
and injurious falls (OR: 1.52, 95%CI: 1.25, 1.84) than those not
taking an SSRI (Table 4). The use of cyclic antidepressants,
antipsychotic medication, anxiolytics and hypnotics were not
associated with falls in this sample.
Table 5 demonstrates that falls risk accumulated for those with a
combination of risk factors, such that women aged 80 years and over
with depressive symptoms and taking antidepressants were 1.85
times (95%CI: 1.17, 2.93) more likely to have multiple falls and 2.69
times (95%CI: 1.65, 4.37) more likely to sustain injury. If the
antidepressant being taken was an SSRI, 61.6% of the group
reported falling and the risk of injury from a fall was 4.96 (95%CI:
2.13, 7.36) compared to those not having that combination of risks.

Depression, antidepressants and falls
Older people currently undertake more then 20% of all primary
care consultations while they are 12% of the population [18] and
the ageing demographic suggests that their care will make up the
majority of primary care within the next half century. Disability
associated with depression is greater than that associated with
physical conditions and the combination of both physical and
mood disorder is associated with the highest levels of disability
[19]. Thus appropriate management of both mood disorder and
falls is essential to protect quality of life and function for older
people.
Independent of other important characteristics leading to falls,
those with clinically significant depressive symptoms were more
likely to report multiple falls, confirming the findings of others[20–
23]. Causality cannot be inferred because of the cross-sectional
design of the study, but available evidence indicates that
depression and depressive symptoms are predictive of falls[24].
Older people with depression have an abnormal gait pattern,[25,26] and postural abnormalities in the standing position,[27] which suggests a physiological rather than psychological
origin for their falls. Depression is also independently related to
fractures,[21] dizziness and increased fear of falling.[28] Both fear
of falling and depression are independently related to stride-tostride variability, itself a marker of falls risk.[26]
It is also possible that falls may lead to depression (reverse
causality) by reducing functional status and increasing disability[29],[30] Whatever the mechanism for the relationship between
depression and falls, the presence of one should trigger an inquiry
for the other and an offer of appropriate remediation.
In this sample, antidepressants were independently related to an
increased risk of falls and injury, confirming studies showing a
similar relationship for those in residential care[5] and in the
community[31]. One half of those taking antidepressants used

Discussion
A number of factors interacted to multiply the risk of falls, such
that over 60% of women older than 80 years with depression and
PLoS ONE | www.plosone.org
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Table 1. Demographic and Clinical Characteristics of Fallers and Non-fallers

Fall during past 12 months
Patient characteristics

Age, mean (sd), years

Overall

71.8 (7.7)

Yes

No

4,974

15,662

73.4 (8.3)

71.3 (7.4)

p value

,0.001

Female, n (%)

12,074 (58.4)

3,258 (66.5)

8,816 (56.3)

,0.001

Australian born, n (%)

15,317 (74.4)

3,715 (74.9)

11,602 (74.2)

0.312

Married or defacto, n (%)

13,810 (67.0)

2,945 (59.3)

10,865 (69.5)

,0.001

Living alone vs with others, n (%)

4,948 (24.0)

1,406 (28.4)

3,542 (22.7)

,0.001

Physically active, n(%)

12,831 (62.7)

2,829 (57.6)

10,002 (64.3)

,0.001

University qualification, n (%)

3,073 (15.2)

761 (15.7)

2,371 (15.0)

0.284

Social support score, mean (sd)

33.9 (4.8)

33.1 (5.3)

34.2 (4.6)

,0.001

Lowest

5,143 (25.7)

1,531 (32.2)

3,612 (23.7)

,0.001

Second

5,063 (25.3)

1,177 (24.8)

3,886 (25.5)

Third

4,567 (22.9)

1,024 (21.5)

3,543 (23.3)

Highest

5,198 (26.0)

1,019 (21.4)

4,179 (27.5)

Social support quartiles, n (%)

BMI group, n (%)
Normal weight

6,992 (37.1)

1,550 (35.0)

5,442 (37.8)

Underweight

321 (1.7)

93 (2.1)

228 (1.6)

,0.001

Overweight

7,452 (39.6)

1,689 (38.1)

5,763 (40.0)

Obese

4,057 (21.5)

1,100 (24.8)

2,957 (20.5)

Antidepressants

2,460 (12.0)

806 (18.9)

1,654 (10.2)

,0.001

Antipsychotics

433 (2.1)

147 (3.4)

286 (1.8)

,0.001

Anxiolitics

894 (4.4)

264 (6.2)

630 (3.9)

,0.001

Hypnotics

1,024 (5.0)

304 (7.1)

720 (4.5)

,0.001

Other CNS drugs

6,590 (32.3)

1,796 (42.0)

4,794 (29.7)

,0.001

Cyclic antidepressants

742 (3.6)

218 (5.1)

524 (3.2)

,0.001

SSRIs

1,233 (6.0)

441 (10.3)

792 (4.9)

,0.001

MAOI

7 (0.03)

1 (0.02)

6 (0.04)

1.000

MAOI-A

69 (0.3)

13 (0.3)

56 (0.3)

0.768

Other antidepressants

450 (2.2)

153 (3.6)

297 (1.8)

,0.001

Arthritis, n (%)

11,763 (57.0)

3,352 (67.4)

8,411 (53.7)

,0.001

Stroke, n (%)

1,508 (7.3)

520 (10.4)

988 (6.3)

,0.001

None

4,321 (20.9)

817 (16.4)

3,504 (22.4)

,0.001

1

6,682 (32.4)

1,354 (27.2)

5,328 (34.0)

2

5,097 (24.7)

1,265 (25.4)

3,832 (24.5)

3 or more

4,536 (22.0)

1,538 (30.9)

2,998 (19.1)

Never smoked

10,628 (51.8)

2,546 (51.8)

8,082 (51.9)

Ever smoked

8,594 (41.9)

2,062 (41.9)

6,532 (41.9)

Currently smoking

1,280 (6.2)

311 (6.3)

969 (6.2)

Abstain

5,033 (24.7)

1,352 (27.6)

3,681 (23.7)

Non-risk alcohol use

10,044 (49.2)

2,327 (47.6)

7,717 (49.7)

High risk alcohol intake

5,326 (26.1)

1,211 (24.8)

4,115 (26.5)

Excellent/very good

7,315 (35.7)

1,280 (26.0)

6,035 (38.8)

Good

8,575 (41.8)

2,015 (40.9)

6,560 (42.1)

Use of medications, n (%)

Type of antidepressant, n (%)

Number of other morbid disorders, n (%)

Smoking status, n (%)
0.964

Alcohol use, n (%)
,0.001

Self-rated health, n (%)

PLoS ONE | www.plosone.org
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Table 1. cont.

Fall during past 12 months
Patient characteristics

Overall

Fair/poor

Yes

No

4,974

15,662

p value

4,603 (22.5)

1,632 (33.1)

2,971 (19.1)

SF12 – PCS score #40, n (%)

6,945 (36.5)

2,351 (53.1)

4,594 (31.4)

,0.001

SF12 – MCS score #40, n (%)

1,470 (7.7)

580 (13.1)

890 (6.1)

,0.001

not at all

1,267 (6.2)

713 (14.4)

554 (3.6)

,0.001

Quite

7,718 (37.7)

2,415 (48.9)

5,303 (34.1)

Completely

11,503 (56.1)

1,811 (36.7)

9,692 (62.3)

Confidence of no falls, n (%)

Depressive symptoms: PHQ-9 n (%)
No depression

14,905 (77.7)

2,926 (65.7)

11,979 (81.3)

Questionable depression

3,680 (19.2)

1,250 (28.1)

2,430 (16.5)

Significant depression

602 (3.1)

279 (6.3)

323 (2.2)

,0.001

HADS anxiety grouping, n (%)
No anxiety

16,612 (84.0)

3,640 (77.7)

12,972 (86.0)

Questionable anxiety

1,887 (9.5)

584 (12.5)

1,303 (8.6)

Significant anxiety

1,268 (6.4)

461 (9.8)

807 (5.3)

,0.001

Ever suicidal thought/attempt, n (%)

3,704 (18.2)

1,192 (24.5)

2,512 (16.3)

,0.001

12-month suicidal thought/attempt, n (%)

899 (10.9)

346 (14.3)

553 (9.5)

,0.001

the numbers reported in each of the cells represent the exact numbers of fallers and non-fallers for each of the exposures. However, because of missing values, the
denominator was not always 4,974 for fallers and 15,662 for non-fallers
BMI = Body Mass Index
PHQ = Patient Health Questionnaire
HADS = Hospital Anxiety and Depression
PCS = physical component summary score of the SF-12
MCS = mental health component summary score of the SF-12
SSRI = Selective Serotonin Reuptake Inhibitor
HADS = Hospital Anxiety and Depression Scale
doi:10.1371/journal.pone.0002423.t001

SSRIs, and their association with falls risk was higher than for
those taking any other psychotropic agents. When SSRIs were
introduced, they were not thought to be associated with higher risk

of falls, however a recent community cohort study found that
SSRIs, but not depression, increased the risk of falls and
fractures.[31] It is also possible in the current study that
prescription bias occurred, with family physicians choosing to
prescribe SSRIs for older adults at increased risk of falls, including
those who have depression with dementia. This potential
unmeasured confounding could not be adequately controlled for
in the current analyses, although health status, physical activity
and comorbidities were taken into account.

Table 2. Falls and Injury In a Primary Care Sample (N = 21,
900)

Falls variables

Total, N

Yes, N %

Slipped tripped or stumbled in
last 12 months

21,596

7,612

35.2

Fallen to the ground in last
12 months

20,636

4,974

24.1

1 fall

2,352

47.3 (of those fallen)

2 falls

1,346

27.1

3 falls

694

13.9

4 falls

287

5.8

5 or more falls

295

5.9

Injury from fall

2,351

45.4% of fallers
11.4% of all

Medical attention for injury

1,813

36.4% of fallers
8.8% of all

Other psychotropic medications
Psychotropic medication use has been recognised as a reversible
cause of falls [3,32]. Hypnotics and antipsychotics were not
associated with increased risk of falls in this study, a finding that is
in contrast to other research [33,34]. It is possible that the
association between falls and hypnotic/antipsychotic use is
stronger in older people in residential care, and that this
association is less pronounced amongst independent community
dwelling people who do not use these medications as commonly.

Limitations
Participation in this study was part of recruitment for a
randomised trial for family physicians about depression and
suicide prevention, and participants were fully informed of the
topic. The response rate to this survey is largely unknown.
Inaccuracy of practice registers, even in nations that depend on the

Number are reported where there was complete data
doi:10.1371/journal.pone.0002423.t002
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Table 3. cont.

Table 3. Characteristics of Older People Sustaining Fall
Related Injury in a Primary Care Sample.

Injurious fall during past
12 months

Injurious fall during past
12 months
Patient characteristics

Age, mean (sd), years

Yes

No*

2,351

19,549

73,6 (8.5)

71.7 (7.6)

Patient characteristics
p value

,0.001

Female, n (%)

1,674 (71.3)

11,201 (57.3) ,0.001

Australian born, n (%)

610 (26.0)

5,003 (25.6)

Married or defacto, n (%)

1,292 (55.1)

0.693

Yes

No*

2,351

19,549

Excellent/very good

559 (24.0)

7,132 (36.8)

Good

959 (41.2)

8,145 (42.0)

Fair/poor

810 (34.8)

4,124 (21.3)

p value

,0.001

SF36 – PCS score #40, n (%)

1,185 (56.6)

6,203 (34.3)

,0.001

13,275 (68.0) ,0.001

SF36 – MCS score #40, n (%)

310 (14.8)

1,266 (7.0)

,0.001

Confidence of no falls, n (%)
,0.001

Lives alone vs with others, n (%)

707 (30.2)

4,618 (23.7)

Physically active, n(%)

1,330 (57.3)

12,324 (63.6) ,0.001

Not at all

376 (16.1)

982 (5.1)

University qualification, n (%)

343 (14.9)

2,832 (14.8)

0.879

Quite

1,184 (50.6)

7,090 (36.6)

Social support score, mean (sd)

33.0 (5.4)

34.0 (4.8)

,0.001

Completely

779 (33.3)

11,304 (58.3)

,0.001

Social support quartiles, n (%)

Depressive symptoms: PHQ-9 n (%)

Lowest

748 (33.3)

4,680 (24.8)

No depression

1,315 (62.7)

14,390 (79.3) ,0.001

Second

539 (24.0)

4,775 (25.3)

Questionable depression

634 (30.2)

3,258 (18.0)

Third

465 (20.7)

4,376 (23.2)

Significant depression

148 (7.1)

488 (2.7)

Highest

492 (21.9)

5,062 (26.8)

Normal weight

745 (33.8)

6,655 (37.3)

Underweight

49 (2.3)

292 (1.64)

Overweight

764 (36.7)

7,116 (39.9)

Ever suicidal thought/attempt, n (%) 591 (25.7)

3,311 (17.3)

,0.001

Obese

525 (25.2)

3,758 (21.1)

12-month suicidal thought/
attempt, n (%)

772 (10.2)

,0.001

,0.001

Anxiety: HADS, n (%)

Body Mass Index group, n (%)
,0.001

Use of medications, n (%)
Antidepressants

466 (19.6)

2,200 (11.2)

,0.001

Antipsychotics

80 (3.4)

394 (2.0)

,0.001

Anxiolitics

150 (6.3)

807 (4.1)

,0.001

Hypnotics

188 (7.9)

938 (4.7)

,0.001

Other CNS drugs

1,032 (43.5)

6,094 (31.0)

,0.001

No anxiety

1,663 (75.4)

15,851 (84.9) ,0.001

Questionable anxiety

297 (13.5)

1,720 (9.2)

Significant anxiety

245 (11.1)

175 (14.9)

1,105 (5.9)

*

Missing data assumed to indicate that no injurious fall occurred during the past
12 months.
PHQ = Patient Health Questionnaire
HADS = Hospital Anxiety and Depression
PCS = physical component summary score of the SF-36
MCS = mental health component summary score of the SF-36
doi:10.1371/journal.pone.0002423.t003

Type of antidepressant, n (%)
Cyclic antidepressants

121 (5.1)

682 (3.5)

,0.001

SSRIs

261 (11.0)

1,075 (5.5)

,0.001

MAOI

1 (0.04)

7 (0.04)

0.598

MAOI-A

9 (0.4)

67 (0.3)

0.711

Other antidepressants

,0.001

88 (3.7)

403 (2.0)

Arthritis, n (%)

1,642 (69.8)

10,832 (55.4) ,0.001

Stroke, n (%)

264 (11.2)

1,348 (6.9)

,0.001

,0..001

register for practice payments, can be more than 30%, particularly
for the older population [35–38] and it has been argued that non
respondents from research involving registers should be excluded
[39–41]. Practice registers are relatively new to Australia and their
accuracy has not been established. It is possible that the true
response rate to this survey was as high as 60%. The low response
rate by family physicians and their patients means that response
bias cannot be dismissed however. Response bias will not affect the
relationship between risk factor and outcome and the large sample
size utilised here made detection of small but important influences
on fall risk possible. The risk factors ascertained here were
determined by self-report and were not externally validated.
Nonetheless, most risk factors identified as independently related
to falls in this analysis are biologically plausible and similar to risk
factors observed in other studies of older populations [6,42,43].
This study was not able to evaluate cognition or balance and gait,
which are common risk factors for falls[44]. While these factors
limit the interpretation of the results, the information gained here
will be of value to primary care providers and researchers
interested in the relative risks of depression, and its treatment, on
falls and injurious falls in older people.

Number of other morbid disorders, n (%)
None

338 (14.1)

4,228 (21.6)

1

601 (25.6)

6,508 (33.3)

2

588 (25.0)

4,818 (24.6)

3 or more

824 (35.0)

3,995 (20.4)

Never smoked

1,243 (53.4)

10,041 (51.7) 0.288

Ever smoked

938 (40.3)

8,143 (42.0)

Currently smoking

145 (6.2)

1,219 (6.3)

Smoking status, n (%)

Alcohol use, n (%)
Abstain

674 (29.2)

4,715 (24.4)

Non-risk alcohol use

1,064 (46.2)

9,534 (49.4)

High risk alcohol intake

567 (24.6)

5,064 (26.2)

,0.001

Preventing falls
The results of this study have implications for prevention. Costeffective falls prevention interventions, such as lower limb

Self-rated health, n (%)
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Table 4. The Association Between Risk Factors, 1 Falls, having 2+falls and Injurious Falls in Older Primary Care Patients: Logistic
Regression Results (All Factors Forced into the Model*)

Odds Ratio for 1 falls
(95% CI) N = 2,352
Age group

Odds ratio for 2+ falls
(95% CI)

Odds Ratio for injurious falls
(95% CI)

60–69

1

1

1

70–79

1.09 (0.97, 1.23)

0.88 (0.77, 1.02)

0.94 (0.83, 1.07)

80+

1.41 (1.19, 1.68)

1.34 (1.12, 1.60)

1.33 (1.12, 1.58)

Gender

Female (cw Male)

1.58 (1.41, 1.76)

1.11 (0.97, 1.27)

1.69 (1.49, 1.92)

Marital status

Married (cw not)

1.07 (0.92, 1.25)

0.81 (0.70, 0.95)

0.84 (0.72, 0.99)

Antidepressants

No

1

1

1

Yes
Cyclic Adx

1.34 (1.16, 1.56)

1.46 (1.25, 1.70)

1.29 (1.12, 1.49)

1.05 (0.80, 1.39)

1.07 (0.83, 1.39)

0.91 (0.70, 1.17)

SSRIs

1.55 (1.26, 1.90)

1.66 (1.36, 2.02)

1.52 (1.25, 1.84)

MAIOs

1.09 (0.97, 1.22)

1.17 (0.24, 5.61)

0.62 (0.26, 1.49)

Other

1.34 (0.94, 1.91)

1.54 (1.09, 2.16)

1.35 (1.00, 1.83)

Antipsychotics

Yes

1.06 (0.76, 1.48)

1.33 (0.95, 1.86)

1.07 (0.77, 1.49)

Anxiolytics

Yes

1.04 (0.79, 1.37)

0.90 (0.69, 1.16)

0.94 (0.74, 1.18)

Hypnotics

Yes

1.16 (0.94, 1.43)

1.11 (0.89, 1.38)

1.06 (0.86, 1.32)

Other CNS drugs

Yes

1.22 (1.09, 1.36)

1.04 (0.92, 1.17)

1.11 (0.98, 1.25)

Depression

(PHQ-9) None

1

1

1

Questionable

1.14 (0.98, 1.33)

1.32 (1.13, 1.53)

1.31 (1.14, 1.50)

Significant

1.19 (0.86, 1.64)

1.70 (1.25, 2.31)

1.71 (1.27, 2.30)

Yes (cw no)

1.36 (1.18, 1.56)

1.48 (1.29, 1.71)

1.37 (1.19, 1.57)

Ever suicidal
Anxiety (HADS)

None

1

1

1

Questionable

0.93 (0.78, 1.12)

1.08 (0.89, 1.30)

1.06 (0.88, 1.26)
1.00 (0.80, 1.25)

Significant

0.70 (0.55, 0.89)

0.92 (0.74, 1.13)

Physical activity

Active (cw not)

1.01 (0.91, 1.13)

1.21 (1.07, 1.37)

1.14 (1.01, 1.29)

Alcohol use

None

1

1

1

Non-risk drinking

1.14 (1.00, 1.30)

1.15 (1.01, 1.32)

1.03 (0.77, 1.38)

Risk drinking

1.08 (0.93, 1.26)

1.06 (0.90, 1.24)

0.99 (0.70, 1.39)

Arthritis

Yes

1.25 (1.11, 1.41)

1.37 (1.22, 1.55)

1.27 (1.13, 1.44)

Stroke

Yes

1.05 (0.85, 1.29)

1.23 (1.02, 1.48)

1.20 (1.00, 1.44)

Medical morbidities

None

1

1

1

1

0.85 (0.74, 0.98)

1.14 (0.94, 1.37)

1.02 (0.85, 1.21)

2

0.96 (0.82, 1.13)

1.42 (1.18, 1.71)

1.12 (0.95, 1.33)

3 or more

1.06 (0.90, 1.25)

1.15 (1.01, 1.32)

1.51 (1.26, 1.82)

PCS #40

Yes (cw no)

1.16 (1.00, 1.33)

1.42 (1.23, 1.63)

1.24 (1.07, 1.43)

Confidence of no falls

Not at all

1

1

1

Quite

0.93 (0.71, 1.21)

0.39 (0.32, 0.46)

0.67 (0.55, 0.81)

Completely

0.79 (0.60, 1.05)

0.12 (0.10, 0.15)

0.40 (0.32, 0.49)

All analyses were adjusted for the effect of clustering. Living arrangement, social support and Body Mass index were forced into the models but were not independently
related to outcomes.
Antidepressants were initially entered in the model as one group (any antidepressant) and then one at a time (cyclic Adx = antidepressants, SSRIs, MAOIs -including
MAOI-A and other antidepressants). cw = compared with, SSRIs: selective serotonin reuptake inhibitors. MAOIs: monoamine oxidase inhibitors. MAOI-A: monoamine
oxidase inhibitor A. PHQ-9 = Patient Health Questionnaire. HADS = Hospital Anxiety and Depression. PCS = physical composite score of the SF-12.
doi:10.1371/journal.pone.0002423.t004

*

strengthening and balance retraining[45], and home hazard
assessment and modification[46,47] are now readily available
and should be consistently offered to those most at risk, including
women over age 80 years with depressive symptoms, especially if a
prescription for antidepressants is being written or renewed. In
addition, progressive resistance training might be an effective
approach to both treat depression and reduce the risk of falls
without resorting to antidepressant medication [48].
PLoS ONE | www.plosone.org

Conclusions
Risk factors associated with sustaining a single and sustaining
multiple falls differ suggesting potential separate mechanisms for
single and multiple falls. Use of antidepressants (most notably
SSRIs) and depressive symptoms are independently associated
with increased risk of falls in later life. The prevalence of falls with
depression means that fall prevention strategies should be a
routine part of the management of depression in older people.
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Table 5. Accumulation of Risk for 1 falls, having 2+ falls and Injury from fall according to Age, Gender, Depression and Treatment
with Antidepressant Medication

Prevalence of falls Odds Ratio for 1 fall
in group n (%)
(95% CI)

Odds Ratio for 2+ falls
(95% CI)

Odds Ratio for
injurious falls (95% CI)

Age 80+ years

1,296/3,733 (34.7)

1.31 (1.14, 1.50)

1.44 (1.26, 1.67)

1.32 (1.16, 1.52)

Age 80+ and female

823/2,201 (37.4)

1.39 (1.16, 1.67)

1.35 (1.14, 1.60)

1.65 (1.40, 1.94)

Age 80+ and female and any depressive symptoms*

387/790 (49.0)

1.43 (1.02, 2.00)

1.52 (1.16, 1.97)

2.02 (1.56, 2.62)

Age 80+ and female and any depression* and taking any
antidepressant

101/169 (59.8)

1.78 (0.99, 3.22)

1.85 (1.17, 2.93)

2.69 (1.65, 4.37)

Age 80+ and female and any depression* and taking
SSRIs#

53/86 (61.6)

2.74 (1.29, 5.86)

3.40 (1.79, 6.45)

3.96 (2.13, 7.36)

All analyses adjusted for the effect of clustering and controlled for marital status, living arrangements, physical activity, social support grouping, body mass index
grouping, arthritis, stroke, multiple medical morbidity, alcohol use, SF-12 physical composite score (PCS), confidence of not falling, anxiety grouping and ever suicide
attempt.
*
any depressive symptoms = questionable and significant categories combined.
#
older adults taking cyclic antidepressants, MAOIs, MAOI-A or other antidepressants were excluded.
SSRI denotes Selective Serotonin Reuptake Inhibitor
doi:10.1371/journal.pone.0002423.t005
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